TABLE OF CONTENTS | |||||||||||||||||||||||||||||||||||||||||
January 2015 Volume 15 Number 1 | |||||||||||||||||||||||||||||||||||||||||
In this issue Research Highlights Reviews Perspectives
| |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
REVIEWS | Top | ||||||||||||||||||||||||||||||||||||||||
Epigenetic control of myeloid cell differentiation, identity and function Damiana Álvarez-Errico, Roser Vento-Tormo, Michael Sieweke & Esteban Ballestar p7 | doi:10.1038/nri3777 In this Review, the authors describe the key epigenetic events that are associated with the differentiation and function of cells of the myeloid lineage, with a particular emphasis on monocytes and macrophages. They detail the epigenetic enzymes that control these events and discuss emerging data that show the importance of epigenetic regulation for 'memory-like' behaviour in innate immune cells. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||
Dendritic cell metabolism Edward J. Pearce & Bart Everts p18 | doi:10.1038/nri3771 This Review describes how key metabolic processes are differentially regulated in dendritic cells (DCs), both during their development and during their participation in active immune responses. The authors discuss the importance of these changes in cellular metabolism for DC function and also explain how both intracellular and extracellular metabolites shape DC biology. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||
Periodontitis: from microbial immune subversion to systemic inflammation George Hajishengallis p30 | doi:10.1038/nri3785 Periodontitis has been linked to systemic inflammatory conditions such as rheumatoid arthritis. In this Review, the author summarizes these links and discusses the mechanisms of microbial immune subversion that tip the balance from homeostasis to disease at oral or distant sites. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||
Clinical blockade of PD1 and LAG3 — potential mechanisms of action Linh T. Nguyen & Pamela S. Ohashi p45 | doi:10.1038/nri3790 Here, two receptors that inhibit T cell functions — programmed cell death protein 1 (PD1) and lymphocyte activation gene 3 protein (LAG3) — are reviewed. Their mechanisms of action are discussed in the context of clinical blockade for cancer therapy and potential biomarkers of the efficacy of therapeutic blockade are proposed. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||
PERSPECTIVES | Top | ||||||||||||||||||||||||||||||||||||||||
OPINION Type 2 inflammation in asthma — present in most, absent in many John V. Fahy p57 | doi:10.1038/nri3786 The discovery that patients with asthma can be dichotomized according to levels of type 2 inflammation, and hence their response to inhibitors of this pathway, promises to enhance our understanding of pathogenic mechanisms and personalized therapies. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||
|
*2013 Journal Citation Report (Thomson Reuters, 2014) |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
No comments:
Post a Comment